GLUCOTRACK INC

GlucoTrack completes a strategic business combination with Lōkahi Therapeutics, securing bridge financing to fuel growth and AI‑driven healthcare innovation.

GlucoTrack Inc. pioneers non‑invasive glucose monitoring, turning pain‑free diabetes care into a market‑driving innovation that investors and patients are watching closely.

GlucoTrack Inc.’s stock price surged 40% after the company announced positive results from its first-in-human clinical trial for an implantable blood glucose monitor.